These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22481199)

  • 1. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
    Károlyi Z; Erós N; Ujszászy L; Nagy G
    Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important cutaneous manifestations of inflammatory bowel disease.
    Trost LB; McDonnell JK
    Postgrad Med J; 2005 Sep; 81(959):580-5. PubMed ID: 16143688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous manifestations in inflammatory bowel disease].
    Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
    Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
    J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: skin complications associated with inflammatory bowel disease.
    Tavarela Veloso F
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():50-3. PubMed ID: 15352894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatological signs during inflammatory bowel diseases.
    Feliciani C; De Simone C; Amerio P
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():15-21. PubMed ID: 19530507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
    Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
    Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucocutaneous manifestations of inflammatory bowel disease.
    Amatore F; Colombel JF; Delaporte E
    Ann Dermatol Venereol; 2024 Sep; 151(3):103301. PubMed ID: 39094469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous manifestations of ulcerative colitis].
    Areias E; Garcia e Silva L
    Med Cutan Ibero Lat Am; 1987; 15(3):185-97. PubMed ID: 3312861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis].
    Tian Y; Li JX; Wang HH; Li RY; Liu XG
    Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin manifestations of inflammatory diseases of the gastrointestinal tract].
    Piette F; Colombel JF; Delaporte E
    Ann Dermatol Venereol; 1992; 119(4):297-306. PubMed ID: 1530244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.